Ajanta Pharma Limited
Kotak Mutual Fund increased its stake in Ajanta Pharma from 1.59% to 3.28%, buying an additional 21,15,286 shares for approximately ₹723.70 Cr. This includes the acquisition of 21.02 lakh shares at ₹2,968 apiece in a block deal where a promoter entity sold shares worth ₹1,024 crore.
A manufacturer of specialty pharmaceutical finished dosages, this company develops and markets formulations across therapeutic categories including ophthalmology, gastroenterology, and dermatology for domestic and international markets. With vertically integrated operations spanning development, manufacturing, and marketing, the company has established a significant presence in India's pharmaceutical sector through its robust distribution network and focus on quality production.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.